Drug Shortage Task Force Finds ‘A Broken Marketplace,’ Say Sharpless, Woodcock

Drug GMP Report
A key cause of U.S. drug shortages is the market’s failure to reward well-developed quality management systems, according to an analysis by an FDA-led interagency task force.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00